Stockreport

Annovis Bio Announces Pricing of Initial Public Offering

Annovis Bio, Inc.  (ANVS) 
PDF BERWYN, Pa., Jan. 28, 2020 (GLOBE NEWSWIRE) -- Annovis Bio, Inc., a clinical stage, drug platform company addressing Alzheimer's, Parkinson's and other neurodegenerati [Read more]